NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the results of a clinical trial.

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

USA: A major phase 3 clinical trial has provided promising evidence that a modified mRNA (modRNA) influenza vaccine may offer ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for developing mRNA vaccines, but don’t be fooled into thinking these life-saving ...

Vials of the Pfizer-BioNTech COVID-19 vaccine are shown in 2023. It was formulated using mRNA technology. Lee S. Weissman USA TODAY NETWORK As a longtime pediatrician in South Carolina, I am deeply ...

Researchers have harnessed mRNA-lipid nanoparticle vaccines to deliver antibody fragments to prevent snakebite-induced muscle ...